NARS1 receives official ORPHAcode: what this means for visibility, research and recognition
We are pleased to share an important milestone for the NARS1 community.
NARS1 is now officially searchable on Orphanet and has been assigned its own ORPHAcode: 730327.
This may sound like a small administrative update, but for rare and ultra-rare disease communities, it is an important step forward. Having an ORPHAcode helps make a condition more visible, more consistently recognised, and easier to identify across healthcare, research and data systems.
For a condition as rare as NARS1, visibility matters.
What is an ORPHAcode?
An ORPHAcode is a unique, stable identification number assigned to a specific rare disease or disorder within the Orphanet database.
Orphanet is an open-access international database dedicated to rare diseases and orphan drugs. It is used by healthcare professionals, researchers, patient organisations, policymakers and others working across the rare disease field.
Many traditional medical coding systems do not provide enough detail to identify individual rare diseases. This can make it difficult to understand how many people are affected by a specific condition, where they are being seen, what services they need, and how they could be included in future research.
ORPHAcodes help address this by giving rare diseases a recognised and specific identifier.
Why does this matter for NARS1?
NARS1 is an ultra-rare genetic disorder. Because it is so rare, families often face long diagnostic journeys, limited information, and a lack of awareness among healthcare professionals.
Having an ORPHAcode helps to:
Improve visibility of NARS1 in clinical and health data systems
Support more consistent recognition of the disorder internationally
Help researchers identify patient cohorts and understand prevalence
Improve data sharing across healthcare and research networks
Strengthen the foundations for future clinical research and treatment development
This is particularly important as the NARS1 community continues to grow and as research into the condition moves forward.
What information is included?
The Orphanet page for NARS1 includes key clinical information linked to the disease code. It describes common clinical manifestations including global developmental delay, primarily language delay and severe motor deficits, intellectual disability, microcephaly, seizures, ataxia, demyelinating peripheral neuropathy, and variable dysmorphism of the face, hands and feet.
It also notes that, to date, 35 cases have been reported in the literature.
The Rory Belle Foundation is referenced as the primary resource on the page.
An international step forward
Another important part of this milestone is that the disorder name and synonyms will be translated across all EU partner countries. Dedicated local teams will also be able to add relevant country-specific information.
This helps make information about NARS1 more accessible across different countries and languages, supporting wider recognition and understanding.
The information about NARS1 will continue to be updated by the Orphanet team on a regular basis, together with experts and involved individuals.
A step towards greater recognition
For families affected by NARS1, every step towards greater visibility matters.
An ORPHAcode does not change the daily reality of living with an ultra-rare condition overnight. But it does help create the infrastructure needed for better recognition, stronger data, improved collaboration, and future research progress.
We are grateful to everyone involved in helping NARS1 become more visible within the rare disease landscape.
You can view the NARS1 Orphanet page here
If your child or family member has a confirmed NARS1 diagnosis, you may wish to share this page with their main doctor, geneticist or specialist clinician and ask whether ORPHAcode 730327 can be referenced on their medical file or hospital record.
This may help ensure NARS1 is recorded as specifically and consistently as possible, supporting better visibility of the condition within clinical and health data systems.